Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: Lancet Gastroenterol Hepatol. 2019 Apr 10;4(6):435–444. doi: 10.1016/S2468-1253(19)30085-8

Figure 2:

Figure 2:

Regional and global estimates for the Population Attributable Fraction (tPAF) of the risks associated with injecting drug use (IDU) to Hepatitis C virus (HCV) transmission from 2018-2030. Medians shown in bars, with 95% credibility intervals shown with red lines.

HHS Vulnerability Disclosure